M1774 in Participants With Metastatic or Locally Advanced Unresectable Solid Tumors

Condition:   Metastatic or Locally Advanced Unresectable Solid Tumors Intervention:   Drug: M1774 Sponsors:   EMD Serono Research & Development Institute, Inc.;   Merck KGaA, Darmstadt, Germany Not yet recruiting
Source: ClinicalTrials.gov - Category: Research Source Type: clinical trials